A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines
about
Vascular channels formed by subpopulations of PECAM1+ melanoma cells.MERTK receptor tyrosine kinase is a therapeutic target in melanoma.Synthetic lethality: emerging targets and opportunities in melanoma.Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.Mechanisms of chromosomal instability in melanoma.IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in MelanomaOncogenic BRAF(V600E) Induces Clastogenesis and UVB HypersensitivityATR Mutations Promote the Growth of Melanoma Tumors by Modulating the Immune Microenvironment.Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancerEffective intra-S checkpoint responses to UVC in primary human melanocytes and melanoma cell linesA prognostic signature of G(2) checkpoint function in melanoma cell lines.Gene expression signatures but not cell cycle checkpoint functions distinguish AT carriers from normal individualsIs activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis?DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas.Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment.Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.
P2860
Q30413784-5EDA45AA-0F98-483E-8E84-42B72AD86E71Q30539324-E7B6DED5-DBF0-410C-AF2E-91DB1B98ED09Q33578398-499257E5-46F8-41AA-BD5F-D05BE3B9550AQ34001762-95C273D5-5956-4A7B-8BD1-D2ADDE6379F6Q34026182-F0B4A03B-9945-4B6E-9CE1-E3DF031574CBQ35564248-78B09D4D-8188-4F54-B787-8A4B9BA0688FQ35818484-0BDDD523-AA90-408B-AEA5-E479C2B15DA5Q36301027-5F573574-B2DB-40C7-872F-39E5A3FA936BQ36306149-98948F70-B029-4DFC-9522-4E2DFFFD9288Q36556389-FE65791C-35F9-4AAD-9B26-F8521F0C5504Q36823687-96E4D922-0CA4-490B-A453-7D4E3D356740Q37234933-B0ADA18A-2199-4B64-8D97-6F3309540573Q37530284-FBD21BF4-5F69-4A34-AFBE-EF68B3A55D60Q38120311-A0FBBABF-F53F-4DA8-8B82-84418FA0D9ABQ39162918-3460B422-2BBD-46E9-86C8-8506FF7686EBQ40058161-6BC7B1D4-DC52-4B18-941B-2ED6584C08FDQ41859401-F7F09DBD-9127-4079-AA59-6CB8CDA07FE8Q54983880-91E9BD35-21E9-4487-913C-AAA8AE7AF1E3
P2860
A prognostic signature of defective p53-dependent G1 checkpoint function in melanoma cell lines
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A prognostic signature of defe ...... unction in melanoma cell lines
@ast
A prognostic signature of defe ...... unction in melanoma cell lines
@en
type
label
A prognostic signature of defe ...... unction in melanoma cell lines
@ast
A prognostic signature of defe ...... unction in melanoma cell lines
@en
prefLabel
A prognostic signature of defe ...... unction in melanoma cell lines
@ast
A prognostic signature of defe ...... unction in melanoma cell lines
@en
P2093
P2860
P1476
A prognostic signature of defe ...... unction in melanoma cell lines
@en
P2093
Alain Sarasin
Bernard Omolo
Craig Carson
Dennis A Simpson
Eldon C Peters
Janiel M Shields
Maria J Sambade
Nancy E Thomas
Patrick Tompkins
P2860
P304
P356
10.1111/J.1755-148X.2012.01010.X
P577
2012-06-01T00:00:00Z